<DOC>
	<DOCNO>NCT02783703</DOCNO>
	<brief_summary>The study team investigate racial difference metabolic clinical response Medium chain triglyceride ( MCT ) African American Caucasian American subject Metabolic Syndrome .</brief_summary>
	<brief_title>Racial Differences MCT Metabolic Syndrome</brief_title>
	<detailed_description>Obese African Americans ( AA ) metabolic syndrome ( MS ) know hyperinsulinemia ( HI ) insulin resistance ( IR ) Caucasian Americans ( CA ) . Racial disparity type 2 diabetes ( T2D ) outcomes adversely affect AA . Medium chain triglyceride ( MCT ) safe effective treatment IR MS widely use . The investigator ' main aim determine effect MCT insulin secretion clearance , insulin sensitivity , beta cell function , disposition index use frequently sample intravenous glucose tolerance test ( FSIVGTT ) Bergman 's minimal model analysis . The study team investigate racial difference metabolic clinical response MCT AA CA subject MS . The investigator aim enroll 12 obese subject ( 6 AA , 6 CA ) MS isocaloric study participant receive MCT supplementation daily 6 week maintain stable weight . Insulin secretion dynamic insulin sensitivity assess intervention FSIVGTT . The investigator hope show MCT effectively reduce HI IR CA AA . These pilot data provide basis NIH grant submission investigate treatment MS MCT mixed racial population .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<criteria>Englishspeaking Premenopausal ( female ) Body Mass Index 3040 Diagnosis metabolic syndrome clinical criterion &gt; least 3 follow : central adiposity triglyceride &gt; =150 mg/dL HDL &lt; =40 mg/dL men &lt; =50 mg/dL woman blood pressure &gt; =130/85 fast glucose &gt; =100 ) hemoglobin A1c &gt; =6.5 use insulin , oral hypoglycemic , agent , insulinsensitizing agent chronic use steroid NSAIDs unstable weight within 3 month prior baseline ( e.g. , weight gain loss &gt; 3 % ) use weight loss medication , bi triphasic hormonal contraceptive sex hormone therapy use psychotropic medication liver kidney disease congestive heart failure severe peripheral vascular disease cancer COPD</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>